Rare Disease Patient Support Program Adherence Script

Role: Lead Healthcare Patient Experience Strategist and Specialty Brand Lifecycle Architect.

Context

• Disease indication: {{indication_name}}
• Mode of administration: {{therapy_administration_mode}}
• Specialty pharmacy network: {{specialty_pharmacy_partner}}
• Clinical support team: {{nurse_support_channel}}
• First adherence milestone: {{adherence_milestone_days}}
• Safety and adverse event pathway: {{adverse_event_reporting_protocol}}

Task

Draft a compassionate, health-literacy-optimized 4-part email onboarding journey script for newly prescribed patients, driving persistence, mitigating anxiety, and coordinating logistical hurdles without providing unapproved medical advice.

Method

1. Establish a reading grade level (6th–8th grade) suitable for health literacy standards across all communications.
2. Script Module 1 (Welcome & Specialty Pharmacy Navigation): De-mystify initial shipment logistics, cold-chain handling, and outreach from {{specialty_pharmacy_partner}}.
3. Script Module 2 (Preparation & Administration Guidance): Explain administration logistics for {{therapy_administration_mode}}, introducing injection/infusion planning guides and nurse support via {{nurse_support_channel}}.
4. Script Module 3 (Financial & Copay Support): Break down foundational access resources, copay card activation, and foundation assistance workflows.
5. Script Module 4 (The Milestone Check-In): Celebrate reaching {{adherence_milestone_days}} on therapy, prompting refill schedules and ongoing lifestyle integration.
6. Embed mandatory FDA-compliant Fair Balance and Black Box warnings (where applicable) alongside {{adverse_event_reporting_protocol}} across every module.
7. Craft distinct callout boxes for caregivers and family support networks in Modules 1 and 2.
8. Include precise opt-out mechanisms, caregiver proxy verification rules, and secure portal links.

Constraints

• MUST be fully compliant with HIPAA privacy rules and contain zero protected health information (PHI) in subject lines.
• MUST NOT provide individual diagnosis, dose adjustment recommendations, or symptomatic medical counsel.
• Every script must clearly present {{adverse_event_reporting_protocol}} in an accessible footer.
• Tone must remain empathetic, empowering, and accessible while strictly adhering to regulatory guidelines.

Output format

• Section 1: Patient Journey Milestones & Triggers (Day 0, Day 7, Day 14, Day {{adherence_milestone_days}})
• Section 2: Module 1 Script (Welcome & Pharmacy Fulfillment Coordination)
• Section 3: Module 2 Script (Administration Preparedness & {{nurse_support_channel}} Access)
• Section 4: Module 3 Script (Co-Pay Navigation & Access Optimization)
• Section 5: Module 4 Script (Milestone Celebration & Habit Formation)
• Section 6: Standardized Safety, Fair Balance, and Adverse Event Reporting Copy Block

Self-review

• Ensure subject lines do not disclose specific diagnostic or clinical conditions (HIPAA de-identification standard).
• Verify that {{adverse_event_reporting_protocol}} is prominently displayed and instructions are unmistakable.
• Check that the language throughout is tuned to an accessible 6th–8th grade reading level.